Literature DB >> 3510149

Azathioprine and prognosis in primary biliary cirrhosis.

E Christensen, J Neuberger, J Crowe, B Portmann, R Williams, D G Altman, H Popper, D Doniach, L Ranek, N Tygstrup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3510149     DOI： 10.1016/0016-5085(86)90972-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis.

Authors:  Tomohiro Katsumi; Masashi Ninomiya; Taketo Nishina; Kei Mizuno; Kyoko Tomita; Hiroaki Haga; Kazuo Okumoto; Takafumi Saito; Tooru Shimosegawa; Yoshiyuki Ueno
Journal:  Lab Invest       Date:  2016-09-26       Impact factor: 5.662

Review 2.  Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.

Authors:  Francesca Saffioti; Kurinchi Selvan Gurusamy; Leonardo Henry Eusebi; Emmanuel Tsochatzis; Brian R Davidson; Douglas Thorburn
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28

Review 3.  Cirrhosis and autoimmune liver disease: Current understanding.

Authors:  Rodrigo Liberal; Charlotte R Grant
Journal:  World J Hepatol       Date:  2016-10-08

4.  TGF-β2 silencing to target biliary-derived liver diseases.

Authors:  Anne Dropmann; Steven Dooley; Bedair Dewidar; Seddik Hammad; Tatjana Dediulia; Julia Werle; Vanessa Hartwig; Shahrouz Ghafoory; Stefan Woelfl; Hanna Korhonen; Michel Janicot; Katja Wosikowski; Timo Itzel; Andreas Teufel; Detlef Schuppan; Ana Stojanovic; Adelheid Cerwenka; Stefanie Nittka; Albrecht Piiper; Timo Gaiser; Naiara Beraza; Malgorzata Milkiewicz; Piotr Milkiewicz; John G Brain; David E J Jones; Thomas S Weiss; Ulrich M Zanger; Matthias Ebert; Nadja M Meindl-Beinker
Journal:  Gut       Date:  2020-01-28       Impact factor: 23.059

Review 5.  Natural history and management of primary biliary cirrhosis.

Authors:  Nadya Al-Harthy; Teru Kumagi
Journal:  Hepat Med       Date:  2012-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.